Terms: = Colorectal cancer AND USP6, TRE2, 9098, ENSG00000129204, TRE17, Tre-2, HRP1 AND Treatment
1 results:
1. Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.
Schmiegel W; Scott RJ; Dooley S; Lewis W; Meldrum CJ; Pockney P; Draganic B; Smith S; Hewitt C; Philimore H; Lucas A; Shi E; Namdarian K; Chan T; Acosta D; Ping-Chang S; Tannapfel A; Reinacher-Schick A; Uhl W; Teschendorf C; Wolters H; Stern J; Viebahn R; Friess H; Janssen KP; Nitsche U; Slotta-Huspenina J; Pohl M; Vangala D; Baraniskin A; Dockhorn-Dworniczak B; Hegewisch-Becker S; Ronga P; Edelstein DL; Jones FS; Hahn S; Fox SB
Mol Oncol; 2017 Feb; 11(2):208-219. PubMed ID: 28106345
[TBL] [Abstract] [Full Text] [Related]
